Paper39192518
Myosteatosis and muscle loss impact liver transplant outcomes in male patients with hepatocellular carcinoma.
Lu D and 14 others. J Cachexia Sarcopenia Muscle, 2024. Cited by 24 papers, by iCite.
Cite this record
ConductScience Library. Myosteatosis and muscle loss impact liver transplant outcomes in male patients with hepatocellular carcinoma. Papers, record 39192518. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39192518
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Myosteatosis and muscle loss impact liver transplant outcomes in male patients with hepatocellular carcinoma.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Liver Transplantation | Major topic |
| Carcinoma, Hepatocellular | Major topic |
| Liver Neoplasms | Major topic |
| Sarcopenia | Major topic |
| Humans | |
| Male | |
| Middle Aged | |
| Prognosis | |
| Muscle, Skeletal | |
| Female | |
| Treatment Outcome | |
| Tomography, X-Ray Computed |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 92159202 | Major Research Plan of the National Natural Science Foundation of China | PubMed | ||
| 2021YFA1100500 | National Key Research and Development Program of China | PubMed | ||
| 81930016 | Key Program, National Natural Science Foundation of China | PubMed | ||
| 82000617 | Young Program of National Natural Science Funds | PubMed | ||
| 2017ZX10203205 | National S&T Major Project | PubMed | ||
| LQ23H160048 | Natural Science Foundation of Zhejiang Province | PubMed |
Source PubMed
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32217938 | Liver Transplantation for Hepatocellular Carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference. | Transplantation | 2020 | https://conductscience.org/library/papers/32217938 | PubMed |
| 2 | 25804634 | Liver transplantation for hepatocellular carcinoma beyond the Milan criteria. | Gut | 2016 | https://conductscience.org/library/papers/25804634 | PubMed |
| 3 | 35395556 | Assessing dynamic change in muscle during treatment of patients with cancer: Precision testing standards. | Clin Nutr | 2022 | https://conductscience.org/library/papers/35395556 | PubMed |
| 4 | 35027442 | Sarcopenia: early prevention or overdiagnosis? | BMJ | 2022 | https://conductscience.org/library/papers/35027442 | PubMed |
| 5 | 35006438 | Cancer metabolism and intervention therapy. | Mol Biomed | 2021 | https://conductscience.org/library/papers/35006438 | PubMed |
| 6 | 37031334 | Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantation. | Hepatol Int | 2023 | https://conductscience.org/library/papers/37031334 | PubMed |
| 7 | 36065509 | The effect of computed tomography parameters on sarcopenia and myosteatosis assessment: a scoping review. | J Cachexia Sarcopenia Muscle | 2022 | https://conductscience.org/library/papers/36065509 | PubMed |
| 8 | 35248726 | Clinical characteristics and survival analysis of liver transplantation in patients with alcoholic liver disease: A single-center retrospective study. | Transpl Immunol | 2022 | https://conductscience.org/library/papers/35248726 | PubMed |
| 9 | 28053342 | Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches. | Nat Rev Gastroenterol Hepatol | 2017 | https://conductscience.org/library/papers/28053342 | PubMed |
| 10 | 29345251 | Cancer-associated cachexia. | Nat Rev Dis Primers | 2018 | https://conductscience.org/library/papers/29345251 | PubMed |
| 11 | 8594428 | Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. | N Engl J Med | 1996 | https://conductscience.org/library/papers/8594428 | PubMed |
| 12 | 29970408 | Predicted lean body mass, fat mass, and all cause and cause specific mortality in men: prospective US cohort study. | BMJ | 2018 | https://conductscience.org/library/papers/29970408 | PubMed |
| 13 | 29318756 | Loss of skeletal muscle during systemic chemotherapy is prognostic of poor survival in patients with foregut cancer. | J Cachexia Sarcopenia Muscle | 2018 | https://conductscience.org/library/papers/29318756 | PubMed |
| 14 | 36417796 | Multi-omics profiling reveals Chitinase-3-like protein 1 as a key mediator in the crosstalk between sarcopenia and liver cancer. | Redox Biol | 2022 | https://conductscience.org/library/papers/36417796 | PubMed |
| 15 | 35794004 | Sarcopenia Determined by Skeletal Muscle Index Predicts Overall Survival, Disease-free Survival, and Postoperative Complications in Resectable Esophageal Cancer: A Systematic Review and Meta-analysis. | Ann Surg | 2022 | https://conductscience.org/library/papers/35794004 | PubMed |
| 16 | 39192518 | Myosteatosis and muscle loss impact liver transplant outcomes in male patients with hepatocellular carcinoma. | J Cachexia Sarcopenia Muscle | 2024 | https://conductscience.org/library/papers/39192518 | PubMed |
| 17 | 35667542 | Experience with solid organ transplantation in patients with previous immunotherapy treatment is still limited but this is changing: The survey-based view of the global transplant society. | Transpl Immunol | 2022 | https://conductscience.org/library/papers/35667542 | PubMed |
| 18 | 31448486 | Myosteatosis to predict inferior perioperative outcome in patients undergoing orthotopic liver transplantation. | Am J Transplant | 2020 | https://conductscience.org/library/papers/31448486 | PubMed |
| 19 | 35068076 | Predicted fat mass and lean mass in relation to all-cause and cause-specific mortality. | J Cachexia Sarcopenia Muscle | 2022 | https://conductscience.org/library/papers/35068076 | PubMed |
| 20 | 36994237 | Metabolic reprogramming in cancer: Mechanisms and therapeutics. | MedComm (2020) | 2023 | https://conductscience.org/library/papers/36994237 | PubMed |
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42942575 | Longitudinal Changes in CT-Derived Vertebral Trabecular Attenuation and Psoas Muscle Density After Liver Transplantation for Hepatocellular Carcinoma. | Medicina (Kaunas) | 2026 | https://conductscience.org/library/papers/42942575 | PubMed |
| 42682768 | The association between sarcopenia and the prognosis of patients with high tumor burden hepatocellular carcinoma receiving hepatic artery infusion chemotherapy combined with lenvatinib and programmed death receptor-1 inhibitor: a multicenter, propensity score matching comparative study. | Front Immunol | 2026 | https://conductscience.org/library/papers/42682768 | PubMed |
| 42241922 | Prognostic role of myosteatosis in predicting MACE and mortality after TAVR: insights from CT-based body composition analysis. | J Nutr Health Aging | 2026 | https://conductscience.org/library/papers/42241922 | PubMed |
| 42122044 | Longitudinal CT-Based Assessment of Muscle and Bone Changes After Liver Transplantation in Hepatitis B Patients with and Without Hepatocellular Carcinoma. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/42122044 | PubMed |
| 42015025 | The impact of low skeletal muscle index and low muscle radiodensity on the prognosis of esophageal squamous cell carcinoma: a multi-center retrospective study in China (TIMES Study). | BMC Cancer | 2026 | https://conductscience.org/library/papers/42015025 | PubMed |
| 41400751 | Myosteatosis: Epidemiological Insights, Functional Decline, and Diagnostic Advances. | Curr Obes Rep | 2025 | https://conductscience.org/library/papers/41400751 | PubMed |
| 41278358 | Low Cystatin C-to-Creatinine Estimated GFR Ratio Predicts Post-Kidney Transplant Cardiovascular Events. | Kidney Int Rep | 2025 | https://conductscience.org/library/papers/41278358 | PubMed |
| 41211064 | Sarcopenia in liver transplantation: A comprehensive bibliometric study of current research trends and future directions. | Open Life Sci | 2025 | https://conductscience.org/library/papers/41211064 | PubMed |
| 41044458 | Changes in nutritional status in hepatocellular carcinoma patients treated with sorafenib. | Support Care Cancer | 2025 | https://conductscience.org/library/papers/41044458 | PubMed |
| 40892254 | Impact of body composition on prognostic stratification and survival in periampullary carcinoma after pancreatoduodenectomy. | Abdom Radiol (NY) | 2026 | https://conductscience.org/library/papers/40892254 | PubMed |
| 40647511 | Perioperative and Oncological Outcome in Patients Undergoing Curative-Intent Liver Resection for Cholangiocarcinoma in the Context of Osteopenia. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40647511 | PubMed |
| 40489025 | Impact of myosteatosis on outcomes after liver transplantation: a systematic review and meta-analysis. | Hepatol Int | 2025 | https://conductscience.org/library/papers/40489025 | PubMed |
| 40377729 | Myosteatosis and the survival of patients with hepatocellular carcinoma: a meta-analysis. | Clin Exp Med | 2025 | https://conductscience.org/library/papers/40377729 | PubMed |
| 40308633 | Prognostic impact of body composition in hepatocellular carcinoma patients undergoing interventional and systemic therapy. | Front Nutr | 2025 | https://conductscience.org/library/papers/40308633 | PubMed |
| 40083684 | Molecular Mechanisms of Ischemia/Reperfusion Injury and Graft Dysfunction in Liver Transplantation: Insights from Multi-Omics Studies in Rodent Animal Models. | Int J Biol Sci | 2025 | https://conductscience.org/library/papers/40083684 | PubMed |
| 40042010 | Comment on "Myosteatosis and Muscle Loss Impact Liver Transplant Outcomes in Male Patients With Hepatocellular Carcinoma" by Lu et al.-The Authors' Reply. | J Cachexia Sarcopenia Muscle | 2025 | https://conductscience.org/library/papers/40042010 | PubMed |
| 39428603 | Comment on 'Myosteatosis and Muscle Loss Impact Liver Transplant Outcomes in Male Patients With Hepatocellular Carcinoma' by Lu et al. | J Cachexia Sarcopenia Muscle | 2024 | https://conductscience.org/library/papers/39428603 | PubMed |
| 39192518 | Myosteatosis and muscle loss impact liver transplant outcomes in male patients with hepatocellular carcinoma. | J Cachexia Sarcopenia Muscle | 2024 | https://conductscience.org/library/papers/39192518 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39192518
GET https://conductscience.org/api/papers/v1/39192518/references?page=2